Is it time for Brazil to prioritize TB preventive therapy for all people living with HIV?

Maciel, Ethel L; Prado, Thiago N do; Andrade, Kleydson Bonfim; Golub, Jonathan E.
Braz. j. infect. dis ; 22(1): 74-75, Jan.-feb. 2018.
Artigo em Inglês | LILACS | ID: biblio-951625

Documentos relacionados

  1. Low uptake of isoniazid window prophylaxis in patients exposed to a health-care worker with pulmonary tuberculosis in a paediatric ward.
  2. Whole-Blood 3-Gene Signature as a Decision Aid for Rifapentine-based Tuberculosis Preventive Therapy.
  3. Cost of Delivering 12-Dose Isoniazid and Rifapentine Versus 6 Months of Isoniazid for Tuberculosis Infection in a High-Burden Setting.
  4. Pragmatic global dosing recommendations for the 3-month, once-weekly rifapentine and isoniazid preventive TB regimen in children.
  5. US Guidelines Fall Short on Short-Course Tuberculosis-Preventive Therapy.
  6. Effect of different interventions for latent tuberculosis infections in China: a model-based study.
  7. Nonparticipation reasons in a randomized international trial of a new latent tuberculosis infection regimen.
  8. Isoniazid level and flu-like symptoms during rifapentine-based tuberculosis preventive therapy: A population pharmacokinetic analysis.
  9. Isoniazid prophylaxis in liver transplant recipient with latent tuberculosis: Is it harmful for transplanted liver?
  10. Factors affecting uptake and completion of isoniazid preventive therapy among HIV-infected children at a national referral hospital, Kenya: a mixed quantitative and qualitative study.